Evidence map›Paper›PMID 37770785›Full record

ArticleBulletin of experimental biology and medicine2023

The Role of cAMP-Dependent Intracellular Signaling Pathways in the Regulation of the Functions of Neural Stem Cells and Neuroglial Cells in Amyloid-β-Induced Neurodegeneration.

G N Zyuz'kov, L A Miroshnichenko, L Yu Kotlovskaya, A V Chaikovskii

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

G N Zyuz'kovLaboratory of Pathophysiology and Experimental Therapy, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. zgn@pharmso.ru.
L A MiroshnichenkoLaboratory of Pathophysiology and Experimental Therapy, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
L Yu KotlovskayaLaboratory of Pathophysiology and Experimental Therapy, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
A V ChaikovskiiLaboratory of Pathophysiology and Experimental Therapy, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Research Institute of Pharmacology and Regenerative Medicine named ED Goldberg · RURussian Academy of Sciences · RUTomsk National Research Medical Center · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under conditions of neurodegeneration modeled in vitro by the β-amyloid peptide-(25-35) fragment (Aβ

Indexed as

Amyloid beta-PeptidesCyclic AMPNeural Stem CellsNeurogliaPeptide FragmentsAdenylyl CyclasesAlzheimer DiseaseAnimalsCell DifferentiationCell ProliferationCells, CulturedCyclic AMP-Dependent Protein KinasesRatsSignal TransductionAdenylyl CyclasesAmyloid beta-Peptidesamyloid beta-protein (25-35)Cyclic AMPCyclic AMP-Dependent Protein KinasesPeptide FragmentsAlzheimer’s diseasecAMPneural stem cellsPKAβ-amyloid

Identifiers

PMID37770785
OpenAlexW4387126626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.